BioMarin Pharmaceutical | Capitale Di Prestito



Loan Capital Cambiamento Data
Acadia Pharmaceuticals USD 0 0 2024-12
Agios Pharmaceuticals USD 0 0 2024-12
Alnylam Pharmaceuticals USD 1.02B 967K 2024-12
Amgen USD 56.55B 305M 2024-12
Bayer EUR 34.55B 2.12B 2024-12
Biogen USD 4.55B 1.4M 2024-12
BioMarin Pharmaceutical USD 595.89M 1.27M 2024-12
Gilead Sciences USD 24.9B 3.46B 2024-12
Incyte USD 33.54M 5.32M 2024-12
Insmed USD 1.13B 147.77M 2024-12
Ionis Pharmaceuticals USD 1.25B 11.67M 2024-12
Moderna USD 39M 586M 2024-12
Neurocrine Biosciences USD 0 0 2024-12
PTC Therapeutics USD 2.12B 179K 2024-12
Regeneron Pharmaceuticals USD 2.7B 720.4M 2024-12
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 12.5B 1.84B 2024-06
Sarepta Therapeutics USD 1.14B 1.16M 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
United Therapeutics USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



BioMarin Pharmaceutical Capitale Di Prestito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.